A practical clinical trial comparing haloperidol, risperidone and olanzapine for the acute treatment of first episode of non-affective psychosis

被引：1
|
作者：
Crespo-Facorro, B. [1 ]
Perez-Iglesias, R. [1 ]
Ramirez, M. L. [1 ]
Pelayo-Terán, J. M. [1 ]
Martinez, O. [1 ]
Vázquez-Barquero, J. L. [1 ]
机构：
[1] Univ Cantabria, HU Marques Valdecilla, E-39005 Santander, Cantabria, Spain
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 86卷
关键词：
D O I：
10.1016/S0920-9964(06)70117-7
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
FC4E
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis
    Crespo-Facorro, Benedicto
    Perez-Iglesias, Rocio
    Ramirez-Bonilla, MariLuz
    Martinez-Garcia, Obdulia
    LLorca, Javier
    Vazquez-Barquero, Jose Luis
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (10) : 1511 - 1521
  • [2] Efficacy and safety of olanzapine, risperidone and haloperidol in acute treatment of patients with first episode psychosis
    Perez, R
    Gonzalez-Blanch, C
    Sierra-Biddle, D
    Martínez, I
    Vazquez-Barquero, JL
    Crespo-Facorro, B
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 298 - 299
  • [3] Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis
    Shim, Joo Cheol
    Choe, Byeong Moo
    Kim, Jung Gee
    Jae, Young Myo
    Kim, Ho Chan
    Kim, Sung Gon
    Kyung, Min
    Kelly, Deanna L.
    Conley, Robert R.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (04) : 400 - 401
  • [4] A naturalistic comparison of atypical (olanzapine, risperidone) and conventional (haloperidol) in the acute treatment of patients with first episode of psychosis
    Perez, R
    Crespo-Facorro, B
    Martinez-Gonzalez, I
    Pelayo-Teran, JM
    Gonzalez-Blanch, C
    Ramirez-Bonilla, ML
    Vazquez-Barquero, JL
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 500 - 501
  • [5] Duration of untreated psychosis in first episode affective and non-affective psychosis
    Gijsman, HJ
    Morgan, C
    Fearon, P
    Lappin, J
    Abdul-Al, R
    Morgan, K
    Dazzan, P
    Mallett, R
    Leff, J
    Jones, P
    Murray, R
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 48S - 48S
  • [6] Pharmacological treatment of first episode non-affective psychosis: Are typical doses of haloperidol for Caucasians appropriate for Asians?
    Wong, J
    Beiser, M
    Zipursky, R
    Bean, G
    PSYCHOSOMATICS, 2000, 41 (02) : 178 - 178
  • [7] Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis
    Arranz, B.
    San, L.
    Ramirez, N.
    Duenas, R. M.
    Perez, V.
    Salavert, J.
    Corripio, I.
    Alvarez, E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 119 (01) : 71 - 77
  • [8] Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: Results of an open retrospective medical record study
    Lambert, M
    Conus, P
    Schimmelmann, BG
    Eide, P
    Ward, J
    Yuen, H
    Schacht, M
    Edwards, J
    Naber, D
    McGorry, PD
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 206 - 213
  • [9] Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone
    Ayesa-Arriola, Rosa
    Manuel Rodriguez-Sanchez, Jose
    Perez-Iglesias, Rocio
    Roiz-Santianez, Roberto
    Martinez-Garcia, Obdulia
    Sanchez-Moreno, Jose
    Tabares-Seisdedos, Rafael
    Vazquez-Barquero, Jose L.
    Crespo-Facorro, Benedicto
    PSYCHOPHARMACOLOGY, 2013, 227 (04) : 615 - 625
  • [10] Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone
    Rosa Ayesa-Arriola
    Jose Manuel Rodríguez-Sánchez
    Rocío Pérez-Iglesias
    Roberto Roiz-Santiáñez
    Obdulia Martínez-García
    Jose Sánchez-Moreno
    Rafael Tabarés-Seisdedos
    Jose L. Vázquez-Barquero
    Benedicto Crespo-Facorro
    Psychopharmacology, 2013, 227 : 615 - 625
12345